Journal of the American College of Surgeons
Volume 202, Issue 4 , Pages 618-622, April 2006

Percutaneous Tracheostomy: A Safe Procedure in the Morbidly Obese

Presented at American College of Surgeons 2005 Spring Meeting, Hollywood, FL, April 2005, and the Keystone Chapter Meeting of the American College of Surgeons, Tannersville, PA, May 2005.

Department of Surgery, Lehigh Valley Hospital, Allentown, PA

Received 17 August 2005; received in revised form 7 December 2005; accepted 12 December 2005.

Background

Percutaneous dilational tracheostomy (PDT) is becoming a widely accepted technique that has replaced open tracheostomy (OT) in many hospitals. One of the remaining relative contraindications is morbid obesity. There are no published case series of its use in this patient population. We reviewed our experience with PDT in the morbidly obese and compared it to OT in this patient population. Our hypothesis is that PDT and OT have a similar frequency of adverse events.

Study design

We reviewed charts of all morbidly obese patients (body mass index [BMI] ≥ 35, calculated as kg/m2) undergoing either PDT or OT at our institution during a 58-month period. Variables examined included age, gender, BMI, diagnosis, bedside or operating room, and bronchoscopy-assisted. We recorded all procedural complications and all tracheostomy-related complications that occurred for 30 days postprocedure or death. Primary adverse end points were defined as procedures that started percutaneous and converted to open; any reoperation related to the initial tracheostomy; malpositioning of tracheostomy resulting in patient morbidity, loss of airway control, and bleeding requiring surgical intervention. Secondary adverse end points occurred when a tracheostomy tube was dislodged or malfunctioned, as in the case of a cuff leak, and any bleeding that occurred more than 24 hours after insertion.

Results

From January 1, 2000, until September 30, 2004, our institution performed 1,062 tracheostomies. One hundred forty-three patients had a BMI ≥ 35. Eighty-nine patients underwent PDT and 53 patients underwent OT. Sixty-seven of the PDTs were performed at the bedside and 22 were performed in the operating room. All OTs were performed in the operating room. Five (6.5%) primary end points were recorded for PDTs (4 conversions to open, 1 malpositioning). Three (6.5%) primary end points were reported for OTs (malpositioning resulting in hypoxia, bleeding requiring surgical intervention, aborted attempt at open).

Conclusions

PDT is a safe procedure to perform on morbidly obese patients.

Abbreviations and Acronyms:  BMI, body mass index , OR, operating room , OT, open tracheostomy , PDT, percutaneous dilational tracheostomy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Competing Interests Declared: None.

PII: S1072-7515(05)01898-3

doi:10.1016/j.jamcollsurg.2005.12.009

Journal of the American College of Surgeons
Volume 202, Issue 4 , Pages 618-622, April 2006